UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

Effect of ambrisentan in patients with systemic sclerosis and mild pulmonary arterial hypertension: long-term follow-up data from EDITA study

Arthritis research & therapy, 2024-07, Vol.26 (1), p.136-10, Article 136

2024

Volltextzugriff (PDF)

Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study)

Arthritis research & therapy, 2019-10, Vol.21 (1), p.217-217, Article 217

2019

Volltextzugriff (PDF)

Prognostic meaning of right ventricular function and output reserve in patients with systemic sclerosis

Arthritis research & therapy, 2022-07, Vol.24 (1), p.1-173, Article 173

2022

Volltextzugriff (PDF)

Hypochromic red cells as a prognostic indicator of survival among patients with systemic sclerosis screened for pulmonary hypertension

Arthritis research & therapy, 2023-03, Vol.25 (1), p.38-38, Article 38

2023

Volltextzugriff (PDF)

Tolerability, safety and survival in patients with severe pulmonary arterial hypertension treated with intravenous epoprostenol (Veletri ® ): a prospective, 6-months, open label, observational, non-interventional study

Respiratory research, 2023-01, Vol.24 (1), p.18-18, Article 18

2023

Volltextzugriff (PDF)

Combined automated 3D volumetry by pulmonary CT angiography and echocardiography for detection of pulmonary hypertension

European radiology, 2019-11, Vol.29 (11), p.6059-6068

2019

Volltextzugriff (PDF)

Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities a cross-sectional cohort study with survival follow-up

Respiratory research, 2020-05, Vol.21 (1), p.127-127, Article 127

2020

Volltextzugriff (PDF)

Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)

Respiratory research, 2018-12, Vol.19 (1), p.258-258, Article 258

2018

Volltextzugriff (PDF)

Oxygenated hemoglobin as prognostic marker among patients with systemic sclerosis screened for pulmonary hypertension

Scientific reports, 2023-02, Vol.13 (1), p.1839-1839, Article 1839

2023

Volltextzugriff (PDF)

Prognostic impact of hypochromic erythrocytes in patients with pulmonary arterial hypertension

Respiratory research, 2021-11, Vol.22 (1), p.288-288, Article 288

2021

Volltextzugriff (PDF)

Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertension

Respiratory research, 2022-03, Vol.23 (1), p.74-74, Article 74

2022

Volltextzugriff (PDF)

Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension-A Genetic Study

International journal of molecular sciences, 2020-05, Vol.21 (9), p.3339

2020

Volltextzugriff (PDF)

Reduction of BMPR2 mRNA Expression in Peripheral Blood of Pulmonary Arterial Hypertension Patients: A Marker for Disease Severity?

Genes, 2022-04, Vol.13 (5), p.759

2022

Volltextzugriff (PDF)

Is iron deficiency caused by BMPR2 mutations or dysfunction in pulmonary arterial hypertension patients?

Pulmonary circulation, 2023-04, Vol.13 (2), p.e12242-n/a

2023

Volltextzugriff (PDF)

Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension

Annals of the rheumatic diseases, 2020-03, Vol.79 (3), p.370

2020

Volltextzugriff (PDF)

Prediction of coronary artery disease by a systemic atherosclerosis score index derived from whole-body MR angiography

Journal of cardiovascular magnetic resonance, 2009-09, Vol.11 (1), p.36-36, Article 36

2009

Volltextzugriff (PDF)

Diagnostic accuracy of automated 3D volumetry of cardiac chambers by CT pulmonary angiography for identification of pulmonary hypertension due to left heart disease

European radiology, 2022-08, Vol.32 (8), p.5222-5232

2022

Volltextzugriff (PDF)

Supervised Exercise Training in Patients with Chronic Thromboembolic Pulmonary Hypertension as Early Follow-Up Treatment after Pulmonary Endarterectomy: A Prospective Cohort Study

Respiration, 2020-08, Vol.99 (7), p.577-588

2020

Volltextzugriff (PDF)

Response to: ' Correspondence on 'Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension'' by Iudici et al

Annals of the rheumatic diseases, 2023-03, Vol.82 (3), p.e66

2023

Volltextzugriff (PDF)

Decompensated right heart failure, intensive care and perioperative management in patients with pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018

International journal of cardiology, 2018-12, Vol.272, p.46-52

2018

Volltextzugriff (PDF)

Effect of Supervised Training Therapy on Pulmonary Arterial Compliance and Stroke Volume in Severe Pulmonary Arterial Hypertension and Inoperable or Persistent Chronic Thromboembolic Pulmonary Hypertension

Respiration, 2021-05, Vol.100 (5), p.369-378

2021

Volltextzugriff (PDF)

Whole-body magnetic resonance angiography for the assessment of extent and severity of extra-cardiac atherosclerosis in patients with newly diagnosed coronary artery disease

Journal of cardiovascular magnetic resonance, 2009-01, Vol.11 (S1), p.P273-P273, Article P273

2009

Volltextzugriff (PDF)

Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry

Respiratory medicine, 2021-03, Vol.178, p.106220-106220, Article 106220

2021

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(38)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Effect of ambrisentan in patients with systemic sclerosis and mild pulmonary arterial hypertension: long-term follow-up data from EDITA study

Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study)

Prognostic meaning of right ventricular function and output reserve in patients with systemic sclerosis

Hypochromic red cells as a prognostic indicator of survival among patients with systemic sclerosis screened for pulmonary hypertension

Tolerability, safety and survival in patients with severe pulmonary arterial hypertension treated with intravenous epoprostenol (Veletri ® ): a prospective, 6-months, open label, observational, non-interventional study

Combined automated 3D volumetry by pulmonary CT angiography and echocardiography for detection of pulmonary hypertension

Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities a cross-sectional cohort study with survival follow-up

Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)

Oxygenated hemoglobin as prognostic marker among patients with systemic sclerosis screened for pulmonary hypertension

Prognostic impact of hypochromic erythrocytes in patients with pulmonary arterial hypertension

Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertension

Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension-A Genetic Study

Reduction of BMPR2 mRNA Expression in Peripheral Blood of Pulmonary Arterial Hypertension Patients: A Marker for Disease Severity?

Is iron deficiency caused by BMPR2 mutations or dysfunction in pulmonary arterial hypertension patients?

Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension

Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial

Prediction of coronary artery disease by a systemic atherosclerosis score index derived from whole-body MR angiography

Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study

Diagnostic accuracy of automated 3D volumetry of cardiac chambers by CT pulmonary angiography for identification of pulmonary hypertension due to left heart disease

Supervised Exercise Training in Patients with Chronic Thromboembolic Pulmonary Hypertension as Early Follow-Up Treatment after Pulmonary Endarterectomy: A Prospective Cohort Study

Response to: ' Correspondence on 'Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension'' by Iudici et al

Decompensated right heart failure, intensive care and perioperative management in patients with pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018

Effect of Supervised Training Therapy on Pulmonary Arterial Compliance and Stroke Volume in Severe Pulmonary Arterial Hypertension and Inoperable or Persistent Chronic Thromboembolic Pulmonary Hypertension

Whole-body magnetic resonance angiography for the assessment of extent and severity of extra-cardiac atherosclerosis in patients with newly diagnosed coronary artery disease

Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry

Aktive Filter

Suchergebnisse filtern